Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Age-restricted cervical screening: HPV testing at age 50 identifies a high risk group for cervical disease.

Cruickshank ME, Chambers G, Murray G, McKenzie L, Donaldson C, Andrew J, Campbell MK, Kitchener HC.

Int J Gynecol Cancer. 2002 Nov-Dec;12(6):735-40.

PMID:
12445251
2.

Risk factors associated with cervical human papillomavirus infections: a case-control study.

Kataja V, Syrjänen S, Yliskoski M, Hippelïnen M, Väyrynen M, Saarikoski S, Mäntyjärvi R, Jokela V, Salonen JT, Syrjänen K.

Am J Epidemiol. 1993 Nov 1;138(9):735-45.

PMID:
8237988
3.

Assessment of risk factors and human papillomavirus (HPV) related pathogenetic mechanisms of CIN in HIV-positive and HIV-negative women. Study design and baseline data of the HPV-PathogenISS study.

Branca M, Costa S, Mariani L, Sesti F, Agarossi A, di Carlo A, Galati M, Benedetto A, Ciotti M, Giorgi C, Criscuolo A, Valieri M, Favalli C, Paba P, Santini D, Piccione E, Alderisio M, De Nuzzo M, di Bonito L, Syrjänen K.

Eur J Gynaecol Oncol. 2004;25(6):689-98.

PMID:
15597844
4.

Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.

Sherman ME, Lorincz AT, Scott DR, Wacholder S, Castle PE, Glass AG, Mielzynska-Lohnas I, Rush BB, Schiffman M.

J Natl Cancer Inst. 2003 Jan 1;95(1):46-52.

PMID:
12509400
5.

Cost-effectiveness of adding human papilloma virus testing to a managed care cervical cancer screening program.

Lonky NM, Hunter MI, Sadeghi M, Edwards G, Bajamundi K, Monk BJ.

J Low Genit Tract Dis. 2007 Oct;11(4):258-64.

PMID:
17917570
6.

Oncogenic human papillomavirus (HPV) infection and uterine cervical cancer: a screening strategy in the perspective of rural India.

Duttagupta C, Sengupta S, Roy M, Sengupta D, Chakraborty S, Bhattacharya P, Roy S, Ghosh S.

Eur J Cancer Prev. 2002 Oct;11(5):447-56.

PMID:
12394242
7.
8.

Prevalence of high-risk human papillomavirus (HR-HPV) types 16 and 18 in healthy women with cytologically negative Pap smear.

Arora R, Kumar A, Prusty BK, Kailash U, Batra S, Das BC.

Eur J Obstet Gynecol Reprod Biol. 2005 Jul 1;121(1):104-9.

PMID:
15950365
9.

Adenocarcinoma of the uterine cervix: the presence of human papillomavirus and the method of detection.

Andersson S, Larson B, Hjerpe A, Silfverswärd C, Sällström J, Wilander E, Rylander E.

Acta Obstet Gynecol Scand. 2003 Oct;82(10):960-5.

PMID:
12956848
10.

Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine.

Goldie SJ, Kohli M, Grima D, Weinstein MC, Wright TC, Bosch FX, Franco E.

J Natl Cancer Inst. 2004 Apr 21;96(8):604-15.

PMID:
15100338
11.
12.
13.

The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.

Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, Scott DR, Rush BB, Glass AG, Schiffman M.

J Natl Cancer Inst. 2005 Jul 20;97(14):1072-9.

PMID:
16030305
14.

Prevalence and persistence of human papillomavirus in postmenopausal age women.

Smith EM, Ritchie JM, Levy BT, Zhang W, Wang D, Haugen TH, Turek LP.

Cancer Detect Prev. 2003;27(6):472-80.

PMID:
14642556
15.

Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003-2005.

Datta SD, Koutsky LA, Ratelle S, Unger ER, Shlay J, McClain T, Weaver B, Kerndt P, Zenilman J, Hagensee M, Suhr CJ, Weinstock H.

Ann Intern Med. 2008 Apr 1;148(7):493-500.

PMID:
18378945
16.

Cost of screening for cancerous and precancerous lesions of the cervix.

Méréa E, Le Galès C, Cochand-Priollet B, Cartier I, de Crémoux P, Vacher-Lavenu MC, Vielh P, Coste J.

Diagn Cytopathol. 2002 Oct;27(4):251-7.

PMID:
12357505
17.

Human papillomavirus in cervical cancer.

Bosch FX, de Sanjosé S.

Curr Oncol Rep. 2002 Mar;4(2):175-83. Review.

PMID:
11822990
18.

Human papillomavirus infections and risks of cervical cancer: what do women know?

Pitts M, Clarke T.

Health Educ Res. 2002 Dec;17(6):706-14.

PMID:
12507346
19.
20.

[Population-based study of human papillomavirus infection in high-risk area for cervical cancer in Shanxi Province, China].

Shen YH, Chen F, Huang MN, Liu B, Wang XX, Zhao FH, Li SM, Li N, Wu LY, Rong SD, Zhang WH, Ren SD, Huang RD, Qiao YL.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2003 Aug;25(4):381-5. Chinese.

PMID:
12974078

Supplemental Content

Support Center